Zantac Lawsuit
A Zantac Lawsuit is an individual legal claim for compensation from personal injury victims who took Zantac diet drugs and were then diagnosed with esophageal cancer. Zantac (as well as the generic variant ranitidine) was found to have the addictive agent tricyclic antidepressant lysine. This drug is known to cause gastrointestinal disturbances including heartburn and abdominal pain. It can also be used to treat ulcerative colitis, chronic diarrhea and gastric ulcers. The FDA has banned the use of lysine in combination with loxapine and does not recommend the drug for treatment of ulcerative colitis, acute diarrhea and gastric ulcers. Zantac Diet Pills, when taken as directed, can help prevent and reduce acid reflux and other digestive disorders.
In July of 2020, there were several cancer lawsuits filed in Florida against Zantac Pharmaceuticals. One of the victims was identified as Bill Cook, a former NASCAR driver. He was diagnosed with esophageal cancer and said that Zantac diet drugs, which contain lysine, "probably" caused his cancer. He is now suing the manufacturer of Zantac, Cepacol, on behalf of his family. His attorney, Robert G. McKee, is seeking financial damages on behalf of Cook's family and has scheduled a preliminary hearing on the issue for late summer.
Zantac Diet Pills and their parent company Cepacol, are the subject of two class action lawsuits. In one, filed in January of 2020 in Florida, a woman is seeking monetary compensation for her loss and suffering following the diagnosis of esophageal cancer. The complaint states that the defendant "admitted that their Zantac product contains a pharmaceutical chemical that causes esophageal cancer but disclaimed liability because the drug was not known to be or used in connection with esophageal cancer." In another case, in September of 2020, a former Zantac employee filed a lawsuit against the drug manufacturers. This individual was diagnosed with esophageal cancer and is seeking damages on behalf of his family. According to the complaint, the defendant failed to warn the individual of the potential cancer risk and did not provide adequate warnings about the possible symptoms of this cancer.
Zantac Diet Pills and its parent company Cepacol do have a class action lawsuit filed in January of 2020 in the United States Federal Court for the Eastern District of Florida. This suit names a number of corporations, including Zantac, GlaxoSmithKline, Myoplex, Metlife, Safeguard and others. Among those named are three manufacturers of gastric-related products including Frova-Glo, Actonel, and Dannon. The complaint further states that defendants failed to warn the individual that a potential problem existed with the ingredients of their products and did not disclose that Galimidi was a possible problem as well.
The Zantac Lawsuit states that the manufacturers have failed to warn individuals of the risk of heartburn when they distributed Zantac to the general public without FDA approval. Specifically, the complaint states that the ingredients in Galimidi, which are derived from an animal digestion process, can cause severe damage to the heart and esophagus, leading to esophagitis, ulcerative colitis, or even cancer. In addition, the complaint states that the manufacturer did not notify the plaintiffs that a diet patch containing Galimidi could lead to a heartburn condition similar to acid reflux. The ingredients in Galimidi are derived from the animal digestive process called Gastro-Esophageal Reflux Disease (GERD). GERD is not the only gastrointestinal condition that can produce symptoms similar to those of a heartburn attack, and if this type of disease is caused by Galimidid, as this does, then the company's negligence in not advising individuals about the dangers of the drug becomes doubly important.
When Zantac Lawsuit becomes part of the litigation, which is expected, it will surely force the manufacturers to take better care of the health of the public who purchase Zantac and use it every day. The company has already admitted that it was one of their mistakes in promoting the product as safe for those who suffer from GERD-related conditions. When individuals with these conditions seek medical treatment, the doctor may recommend that they discontinue using the medicine, but sometimes it is too late. The Zantac Lawsuit will force the companies to make changes to their marketing strategies and better human health practices before a case goes to court.
